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Prenatal exposure of the developing brain to various types of environmental stress increases 
susceptibility to neuropsychiatric disorders such as autism, attention deficit hyperactivity 
disorder and schizophrenia. Given that even subtle perturbations by prenatal environmental 
stress in the cerebral cortex impair the cognitive and memory functions, this review focuses 
on underlying molecular mechanisms of pathological cortical development. We especially 
highlight recent works that utilized animal exposure models, human specimens or/and 
induced Pluripotent Stem (iPS) cells to demonstrate: 1. molecular mechanisms shared by 
various types of environmental stressors, 2. the mechanisms by which the affected 
extracortical tissues indirectly impact the cortical development and function, and 3. 
interaction between prenatal environmental stress and the genetic predisposition of 
neuropsychiatric disorders. Finally, we discuss current challenges for achieving a 
comprehensive understanding of the role of environmentally disturbed molecular 
expressions in cortical maldevelopment, knowledge of which may eventually facilitate 
discovery of interventions for prenatal environment-linked neuropsychiatric disorders. 
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The development of the cerebral cortex consists of very intricate multifaceted steps 
including proliferation/differentiation of neural progenitor cells, neuronal migration and 
maturation [1] [2] [3] [4] [5] [6] [7] [8] [9], and it can be impaired by exposure to 
environmental stress [10] [11] [12]. Even subtle disturbances in the development of the 
cerebral cortex impair cognitive and memory functions [13] [14]. Accordingly, ever 
increasing attention is being paid to understanding the underlying non-genomic alterations 
thought to govern impairment. 
 Alcohol is known as one of the most prevalent prenatal environmental stress, and 
prenatal alcohol exposure-linked impairments are categorized under the term “Fetal 
Alcohol Spectrum Disorder (FASD)”. FASD patients show higher rates of co-morbidity 
with various types of neuropsychiatric problems, such as attention deficit hyperactivity 
disorder (ADHD) and epilepsy [15]. Histological analysis using postmortem tissues from 
FASD patients documented various anomalies in the brain, including heterotopias, 
microcephaly, hydrocephaly and agenesis of the corpus callosum [16] [17] [18]. Many of 
these morphological phenotypes, as well as behavioral phenotypes of human patients, have 
been reproduced by non-human primate, rodent and other vertebrate models of fetal alcohol 
exposure, and therefore, these animal models have been used for understanding etiology of 
FASD and other health problems linked to prenatal alcohol exposure [19] [20] [21] [22]. 
Furthermore, these animal studies found that fetal alcohol exposure particularly affects the 
development of the cerebral cortex, in multiple cellular events including proliferation, 
differentiation, apoptosis, migration, synaptogenesis and dendritogenesis, depending on the 
regimens and timing of exposure [11] [23] [24]. 
 Similarly, clinical and epidemiological studies identified a variety of environmental 
stressors, exposure to which increases the risk of neuropsychiatric diseases [25].  
Importantly, rodent and non-human primate models of prenatal exposure to those 
environmental factors, including hypoxia [26] [27], drugs such as cocaine [11] [28] [29] 
[30] [31] [32] [33], and heavy metals such as methylmercury [34] [35], have shown that 
these factors cause similar structural anomalies in the cortex as well as similar abnormal 
behaviors [11]. These findings imply that different environmental challenges provide 
common impacts on cortical development, thereby resulting in similar endophenotypes. 
Here, we review recent publications that found molecular mechanisms underlying 
pathological cortical development elicited by exposure to prenatal environmental stress and 
discuss how various types of prenatal environmental stress similarly affect cortical 
development and increase the risk of neuropsychiatric disorders. 
 
Early response genes that protect or disturb cortical development under the 
conditions of exposure to environmental stress 
Based on recent findings using prokaryotes, genes that respond (either by increase or 
decrease of expression) to environmental stress can be classified mainly into 2 groups [36] 
[37] [38]. The first group consists of genes that exhibit altered expression immediately 
upon exposure to multiple types of environmental insult. The second group consists of 
genes that exhibit altered expression profiles only upon exposure to specific types of 
environmental stress and are generally altered gradually post exposure. Thus, orchestrated 
changes in the activities of these two types of genes are likely to occur in developing 
cortices. The following section focuses on the first group of genes that immediately respond 
to environmental stress and may lead to common endophenotypes [39], discussing how 
these genes change the molecular landscape of cortical development and contribute to the 
pathogenesis elicited by prenatal environmental stress.  
 
1. Stress responsive signaling 
The cellular stress activates multiple signaling pathways that are well positioned to help 
restore homeostasis upon sudden environmental changes, or, in the long run, enforce a new 
gene expression program so cells can tolerate the new environment. These signaling 
pathways and genes include molecular chaperone encoding genes, genes involved in the 
unfolded protein response, Mitogen-Activated Protein Kinase (MAPK) and Growth Arrest 
and DNA Damage 45 (GADD45) signaling pathways [40]. The Heat Shock Protein (HSP) 
pathway is a major molecular chaperone signaling pathway, the activation of which has 
been identified as one of immediate molecular responses to various types of environmental 
stress, including alcohol, heat, heavy metals and viral infection [35] [41] [42].  
 Our recent study using knockout mice of Heat shock factor 1 (Hsf1), a canonical 
transcription factor that controls transcription of Hsp genes revealed that activation of this 
signaling is required to reduce the risk of cortical malformation, such as heterotopias and 
small size of the cortex, upon prenatal exposure to various types of environmental stress, 
thereby reducing susceptibility to epilepsy [35]. Histological analysis immediately after 
prenatal stress exposure revealed that the increase of these cortical malformations in Hsf1 
knockout mice is due to the increase of cell death and suspension of cell cycling, suggesting 
Hsf1’s roles in cellular protection against environmental stress. Interestingly, the canonical 
downstream targets of Hsf1, Hsps mediate proapoptotic effects of Hsf1 but not the effects 
on cell cycling (Fig.1). El Fatimy et al., (2014) showed that, many cortical genes that are 
critically involved in the control of cell cycling/proliferation and the neuronal migration are 
under the control of Hsf1 and the family gene Hsf2 [43]. Thus the activation of HSF1 
immediately alters expressions of various types of genes to protect the embryonic cortex 
from environmental stress.  
Another example of a stress responsive transcriptional factor that protects the fetal 
brain from prenatal environmental stress is Nuclear Factor Erythroid 2-Related Factor 2 
(Nfe2l2/Nrf2). The transcriptional activity is increased in response to such as alcohol [44], 
kainate induced excitotoxic damage [45] and hydrogen peroxide induced oxidative stress 
[46]. The target genes include multiple genes that encode antioxidant proteins [47] [48].  
Prenatal exposure to methamphetamine (speed) plus Nrf2 loss of function lead to reduced 
motor activity, smaller body weight etc. in the offspring [49]. Interestingly, the gender 
dependent differences were observed in the severity of the phenotypes. 
These lines of evidence suggest that multiple cellular mechanisms provoked by the 
stress response genes act to ensure fetal cortical tolerance to environmental stress, and thus 
decrease the prevalence and severity of ensuing neuropsychiatric diseases [35]. 
 
2. MicroRNAs 
Post-transcriptional controls have been demonstrated to be critically involved in the control 
of normal cortical development [50] [51] [52]. MicroRNAs (miRNAs) are non-coding 
RNAs that are involved in post-transcriptional regulation of the expression of a wide 
variety of genes [53]. Because of their nature as short RNAs for post-transcriptional 
regulation of genes, they are likely to change the molecular landscape of the cell 
immediately and temporally in response to environmental challenges [54]. 
In a comprehensive miRNA profiling study using a neurosphere model of alcohol 
exposure, Miranda and his colleagues found a reduction in expressions of miR-21, miR-335, 
miR-9, and miR-153 24 hours after exposure [55]. 
MiR-9 knockout mouse displays smaller brain size [56]. The analysis of those 
embryonic brains suggested that impaired proliferation and differentiation of neural 
progenitor cells in stage dependent manner may lead to the smaller brain. Consistent with 
this in vivo observation, miR-9 knockdown inhibited the proliferation and promoted the 
migration of the neural progenitor cells in vitro [57]. The control of these biological events 
by miR-9 may be mediated by controlling expression levels of the downstream targets such 
as Forkhead box G1 (Foxg1/Bf1) [56] [58], embryonic lethal, abnormal vision, Drosophila 
like 2 (Elavl2/HuB) [55], Fibroblast growth factor receptor 1 (Fgfr1) [59], Forkhead box 
P2 (Foxp2) [59],  Stathmin 1 (Stmn1) [57], Nuclear receptor subfamily 2, group E, member 
1 (Nr2e1/Tlx) [56] [60], Inhibitor of DNA binding 4 (Id4) [58], Paired box 6 (Pax6) [56], 
Meis homeobox 2 (Meis2) [56], GS homeobox 2 (Gsh2) [56], Islet1 (Isl1) [56], RE1-
silencing transcription factor (Rest) [61], and Actin-like 6A (Actl6a/BAF53a) [62]. Thus 
reduced expression of miR-9 by alcohol exposure is also likely to inhibit those events by 
the similar mechanism. The miR-153 and miR-21 also similarly control the cellular 
proliferation [63] [64]. 
  Reduction of miR-9 expression and the target gene expressions in the zebrafish 
whole-embryo [65] and the embryonic forebrain [59] exposed to alcohol also supports this 
hypothesis. However, in the conditions of exposure to different contexts of maternal stress 
induced by such as restraint of the body and forced swimming, expression of miR-9 was 
increased in the brain of offspring [66]. Similarly, the expression of miR-21 has also been 
reported to be increased in the different ambience, such as in the mouse brain exposed to 
ionizing radiation [67], in the endothelial cells under the exposure to shear stress [68], and 
in the embryonic fibroblasts exposed to arsenite [69]. The expression of miR-153 is also 
upregulated by hydrogen peroxidase induced oxidative stress [70] and nicotine exposure 
[71]. These lines of evidence indicate that the microRNAs are susceptible to the 
environmental changes and that the overall changes of various types of microRNAs may 
determine the phenotypes specific to types/regimens of the environmental stress exposure. 
The fact that miR-335 knockdown reverses the effects of miR-21 knockdown in the cell 
proliferation and death also supports this possibility [55].  
 
Maternal, placental and extracortical tissues exhibit indirect effects as a result of 
environmental stress.  
Beside direct molecular changes within embryonic cortical cells, evidences exist that 
indirect impacts of environmental stress from maternal, placental and other extracortical 
tissues exert a critical influence on cortical development [72]. 
Maternal infection is well defined by epidemiological studies as a risk factor for 
neurodevelopmental disorders such as autism and schizophrenia [73] [74] [75]. Mouse 
offspring that have been exposed to maternal infection display abnormalities reminiscent of 
the behavioral, histological and molecular characteristics of autism [76], while fetal brain 
infection does not cause these abnormalities [74]. Mouse offspring exposed to maternal 
immune activation (MIA), which is elicited by poly-riboinosinic-polyribocytidylic acid or 
lipopolysaccharide, also reproduce the behavioral and histological abnormalities of autism 
[77] [78] [79] [80], suggesting that activation of maternal immune system triggered by 
infection is critical for manifestation of deficits. These early findings have proven MIA 
model useful in the investigation of the molecular mechanisms at play in unraveling 
maternal effects on the pathophysiology of autism. 
Smith and colleagues demonstrated that a proinflammatory cytokine interleukin-6 (IL-
6) supplied from the maternal tissues might mediate the MIA effects on the fetal cortex 
[78]. A single maternal injection of IL-6 in the middle of corticogenesis causes deficits in 
prepulse inhibition and lateral inhibition in the offspring [78], both of which are linked to 
autism and schizophrenia [81] [82] [83] [84]. They also demonstrated that inhibition of IL-
6 by application of the antibody or using the knockout dam, significantly ameliorated such 
as cognitive and exploratory deficits in mouse offspring exposed to MIA [78]. The gene 
expression profiles were also reversed by inhibition of IL-6 in the cortices of the MIA 
offspring. These results provided evidence that IL-6 may owe the indirect effects of MIA on 
fetal cortical development. 
Indirect effects of MIA on cortical development may also involve the effects from 
gastrointestinal tissues of offspring. Autism is often associated with gastrointestinal barrier 
defects [85] [86], and rodent MIA models reproduce these defects [87]. Hsiao E. and 
colleagues made an interesting observation that probiotic treatment of gastrointestinal 
barrier defects improved behavioral abnormalities such as anxiety-like behavior, decreased 
prepulse inhibition, and deficits in ultrasonic vocal communication in the MIA offspring. 
Their study also suggested the possibility that gastrointestinal barrier deficit-induced 
increase of serum metabolites such as 4-ethylphenylsulfate, indolepyruvate, glycolate, 
imidazole propionate, and N-acetylserine, may contribute to behavior abnormality in the 
MIA offspring [87]. Of these, the most dramatically affected metabolite, 4-
ethylphenylsulfate, has been known as a uremic toxin, and the administration of this 
metabolite induces anxiety-like behavior in the mouse [87]. As a recent study suggested the 
link between the uremic toxin and the depression in the chronic kidney disease [88], the 4-
ethylphenylsulfate in serum may be the common factor that affects the brain function in 
various pathophysiological conditions. 
Serotonin derived from placenta may also indirectly affect embryonic brain 
development. Recent studies demonstrated that the placenta is the major source of serotonin 
at early embryonic stage, while the dorsal raphe nuclei in the hindbrain take over from late 
embryonic stage to adulthood [89]. Abnormal serotonin levels in the brain have been linked 
to autism [90] [91] [92], and the role of serotonin in the normal development of 
thalamocortical projections also has been reported [93]. In addition, it has been 
demonstrated that prenatal intake of selective serotonin reuptake inhibitors increases the 
risk of cognitive impairment in mouse progeny [94] [95]. Importantly, serotonin level is 
lower in the cortices of the offspring exposed to environmental stress such as maternal 
infection [96] [97] and cocaine [29]. Therefore environmental stressors may indirectly 
affect the cortical development as a result of disruption in the synthesis/release of serotonin 
in/from the placenta [72]. 
Interaction between a susceptible genotype and environmental risk factors 
Genome wide association studies have shown a polygenic component contributes to the 
risk of schizophrenia and autism [98]. Similarly, many epidemiological studies as well as 
the aforementioned results from studies of animal exposure models have shown these 
disorders also include a “polyepigenetic” component that is influenced by various types of 
environmental stress [10] [99] [100] [101] [102]. However, just how the polyepigenetic 
component increases the risk of disease manifestation by interacting with polygenic 
component is largely unknown.   
 One relatively new approach to help answering this question is the use of induced 
Pluripotent Stem (iPS) cells taken from subjects diagnosed with polygenic diseases such as 
schizophrenia or autism. iPS cells are not only becoming useful tools to obtain functional 
human cortical neurons [103] [104] [105] [106] for understanding the pathogenesis of 
disease, but are also being utilized for drug screening [107]. To examine potential 
interactions between genetic predisposition and the environmental risk factors, we recently 
used iPS cells derived from schizophrenia patients, and exposed the differentiated neural 
progenitor cells to environmental stress including alcohol, methylmercury and hydrogen 
peroxide. Single cell RNA detection revealed augmented cell-to-cell variable activation of 
HSF1-HSP signaling in the schizophrenia patients’ neural progenitor cells, individual cell 
lines of which carry different genetic risks for schizophrenia (Fig.2). This finding suggests 
that variable responses of HSF1-HSP signaling among a population of neural progenitor 
cells exposed to environmental stress is predetermined by genetic predisposition and may 
increase the risk of the onset of schizophrenia as well as other neuropsychiatric diseases 
[35] [108]. 
Using Disrupted-in-schizophrenia-1 gene (Disc1) mutant mice combined with MIA, in 
vivo evidence for the interaction of gene and prenatal environment in the pathogenesis of 
schizophrenia and depression was also provided. The Disc1 is one of the risk genes for 
psychiatric disorders such as schizophrenia and mood disorders [109] [110]. The transgenic 
mice expressing the dominant negative form of Disc1 that was found in the patient [110], 
displayed hyperactivity and impaired social interaction [111]. When this transgenic mouse 
was subjected to MIA, neurobehavioral phenotypes such as anxiety, depression-like 
behavior, and a decrease in social interaction and an increase in aggressiveness were 
unraveled [112]. Two other Disc1 mutant mouse lines with point mutations at Q31L and 
L100P, which show schizophrenia and depression related phenotypes, respectively [113], 
were also subjected to MIA. MIA exposure augmented the impairment in prepulse 
inhibition, lateral inhibition, spatial object recognition, and social motivation of those Disc1 
mutant mice [114]. Importantly, the production of IL-6 was concomitantly increased by the 
combination of Disc1 mutations and the MIA in the fetal mouse brains [114]. Thus these 
mouse models that combine Disc1 mutation and MIA will become powerful models for 
understanding the molecular mechanisms underlying interactions between the gene and 
prenatal environmental factors that increase the risk of the psychiatric diseases. 
 
Outlook 
As outlined in this review, research on polyepigenetic mechanisms associated with many 
types of environmental stress that disturb cortical development and on potential 
prophylactic or preventative interventions of these disturbances are just beginning to 
emerge. To further facilitate this type of research, patient-derived iPS cells will become one 
of several powerful tools. Although there are a number of limitations in their use, easy 
application of environmental stress and the potential for high throughput analysis 
substantiate their usefulness. Challenges include: 1. limited availability of iPS cell lines that 
are fully characterized; 2. lack of validated differentiation protocols for specific types of 
neurons; and 3. lack of validated in vivo approaches (e.g., efficient transplantation methods 
to animal models, etc.) that allow observation of the iPS cells during cortical development. 
A type of the environmental stress can lead to various phenotypes in the cerebral 
cortex, however this variability cannot be explained exclusively by different regimens of 
exposure. Recent studies have revealed potential factors that may affect the resultant 
phenotypes, including gender [49] [115] and probabilistic molecular responses of individual 
cells to the environmental stress [35] (Fig.2) etc. Thus the next important questions will be: 
1. if such molecular differences of individual cells elicited by environmental stress are 
sustained for long periods of time and ultimately result in altered cortical function, and 2. 
which molecules mediate the gender specific effects of prenatal environmental stress. 
 Another recent interesting observation that needs to be addressed at the molecular 
level is the transgenerational effects of prenatal exposure to environmental stress, as 
reported in the cases of alcohol [116]. This observation opens up a whole new field of 
research that might eventually lead to an understanding of why FASD and other 
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Figure 1   
HSF1-mediated protection of neural progenitor cells from various types of 
environmental stress 
Upon exposure to environmental stress, HSF1 is activated and HSPs transcribed by HSF1 
inhibit cell death. HSF1 also keeps cell cycling/proliferation under stress exposure. The 
downstream player X is still unknown. 
Figure 2   
Cell-to-cell variability of HSF1 activation in response to environmental challenges is 
increased in schizophrenia neural progenitor cells.  
The number of cells that are in the levels of excess or very little activation of HSF1 was 
increased in the schizophrenia cells [35]. These outlier cells may be at the risk of 
manifesting pathophysiological features (indicated by the cells surrounded by broken lines). 
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